2023-507340-36-00CompletedPhase 1
A study to investigate the safety, tolerability, and pharmacokinetics of Ent001 in patients with moderately to severely active ulcerative colitis
Source: EU CTIS (euclinicaltrials.eu) · Last updated 7 Jul 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 15 Nov 2023
- Start date
- 22 Apr 2024
- Lead sponsor
- Enthera S.r.l.
- Diseases
- Ulcerative colitis
- EU CT number
- 2023-507340-36-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 40
- 5 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Diagnostics And Consultation Center Convex Ltd. | Sofiya | Bulgaria | Completed |
| Multiprofile Hospital for Active Treatment Sveta Sofia | Sofiya | Bulgaria | Completed |
| Clinexpert Kft. | Gyongyos | Hungary | Completed |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Completed |
| Arensia Clinics S.R.L. | Bucharest | Romania | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.